Zanosar 1 g/10mL
Streptozocin · POWDER, FOR SOLUTION · ESTEVE PHARMACEUTICALS, S.A.
Zanosar (streptozocin) is a chemotherapy medication given by injection into the vein to treat certain types of cancer, including pancreatic cancer and carcinoid tumors. It works by damaging cancer cell DNA to stop cancer growth.
Key Facts
- Brand Name
- Zanosar
- Generic Name
- Streptozocin
- NDC Code (Product)
68118-100- Manufacturer
- ESTEVE PHARMACEUTICALS, S.A.
- Strength
- 1 g/10mL
- Dosage Form
- POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Drug Class
- Alkylating Drug [EPC]
- Marketing Start
- 07/10/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Zanosar used for?
Zanosar (streptozocin) is a chemotherapy medication given by injection into the vein to treat certain types of cancer, including pancreatic cancer and carcinoid tumors. It works by damaging cancer cell DNA to stop cancer growth.
Is Zanosar a controlled substance?
Zanosar is not classified as a controlled substance by the DEA.
What is the generic name for Zanosar?
The generic name for Zanosar is Streptozocin. There are no other listed brand versions of Streptozocin.
What is the NDC code for Zanosar 1 g/10mL?
The NDC (National Drug Code) for Zanosar 1 g/10mL is 68118-100, listed by ESTEVE PHARMACEUTICALS, S.A..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)